Mark A. Varney

Chief Scientific Officer at Psychogenics, Inc.

Mark A. Varney

Mark A. Varney

Chief Scientific Officer at Psychogenics, Inc.

Overview
Career Highlights

RespireRx Pharmaceuticals, Inc.

RelSci Relationships

2758

Number of Boards

2

Birthday

1967

Age

53

Relationships
RelSci Relationships are individuals Mark A. Varney likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former General Manager, Worldwide Diagnostic Business Group at Bayer AG

Relationship likelihood: Strong

Founder at T. Morgen Capital LLC

Relationship likelihood: Strong

Chief Financial Officer, Secretary, Treasurer, Director & Senior Vice President at RespireRx Pharmaceuticals, Inc.

Relationship likelihood: Strong

Vice President & Chief Financial Officer at Lixte Biotechnology Holdings, Inc.

Relationship likelihood: Strong

Director at Psychogenics, Inc.

Relationship likelihood: Strong

Director at Psychogenics, Inc.

Relationship likelihood: Strong

Former Vice Chairman at Catholic Medical Mission Board, Inc.

Relationship likelihood: Strong

Treasurer at National Conference for Community & Justice

Relationship likelihood: Strong

Co-Founder at Vector Fund Management LP

Relationship likelihood: Strong

Former Associate Deputy Administrator at National Aeronautics & Space Administration (NASA)

Relationship likelihood: Strong

Paths to Mark A. Varney
Potential Connections via
Relationship Science
You
Mark A. Varney
Chief Scientific Officer at Psychogenics, Inc.
Education
B.Sc. in Biochemistry

The University of Surrey is located on a beautiful, leafy campus in Guildford, just 30 miles from London. Since 1891, Surrey has been dedicated to solving global challenges, leading research and innovation, and fuelling generations of students with a spirit of curiosity and a desire to improve the world they live in.

Ph.D. & Postdoctoral Training

Oxford is a collegiate university, consisting of the central University and colleges. The central University is composed of academic departments and research centres, administrative departments, libraries and museums. The 38 colleges are self-governing and financially independent institutions, which are related to the central University in a federal system. There are also six permanent private halls, which were founded by different Christian denominations and which still retain their Christian character.

Career History
Chief Scientific Officer
2019 - Current

Psychogenics, Inc. specializes in preclinical neurobiology solutions. It offers animal models, behavioral tests, histology/immunohistochemistry, microdialysis/bioanalysis, electrophysiology, molecular biology and pharmacology. The company was founded by Eric Nestler, Benjamin S. Bunney and Daniel Goodman and is headquartered in Paramus, NJ.

President & Chief Executive Officer
2006 - 2013

RespireRx Pharmaceuticals, Inc. engages in the discovery, development and commercialization of innovative pharmaceuticals for the treatment of neurological and psychiatric disorders. The company was founded by Carl W. Cotman, Wayne Pambianchi and Gary S. Lynch on February 10, 1987 and is headquartered in Glen Rock, NJ.

Vice President & Head-Discovery
2004 - 2006

Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. Sunovion’s vision is to lead the way to a healthier world. The company’s spirit of innovation is driven by the conviction that scientific excellence paired with meaningful advocacy and relevant education can improve lives. With patients at the center of everything it does, Sunovion has charted new paths to life-transforming treatments that reflect ongoing investments in research and development and an unwavering commitment to support people with psychiatric, neurological and respiratory conditions. Headquartered in Marlborough, Mass., Sunovion is an indirect, wholly-owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. Sunovion Pharmaceuticals Europe Ltd., based in London, England, and Sunovion Pharmaceuticals Canada Inc., based in Mississauga, Ontario, are wholly-owned direct subsidiaries of Sunovion Pharmaceuticals Inc.

Transactions
Details Hidden

RespireRx Pharmaceuticals, Inc. raised money in a private placement transaction

Details Hidden

RespireRx Pharmaceuticals, Inc. raised money in a private placement transaction

Details Hidden

RespireRx Pharmaceuticals, Inc. raised money in a private placement transaction

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Mark A. Varney. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Mark A. Varney's profile does not indicate a business or promotional relationship of any kind between RelSci and Mark A. Varney.